Bempedoic Acid and Its Fixed-dose Association With Ezetimibe Also Approved in Europe to Lower Cholesterol and Reduce Cardiovascular Risk
Pharma Focus Europe
by
2d ago
The European Commission has approved the extension of the indications of both bempedoic acid and the fixeddose combination of bempedoic acid and ezetimibe ..read more
Visit website
AbbVie Completes Acquisition of Landos Biopharma
Pharma Focus Europe
by
2d ago
AbbVie announced today that it has completed its acquisition of Landos Biopharma Inc With the completion of the acquisition Landos is now part of AbbVie Landos lead investigational asset is NX a firstinclass oral NLRX agonist which is currently in Phase for the treatment of moderate to severe ..read more
Visit website
Sandoz Receives European Commission Approval for Wyost® and Jubbonti®, the First and Only Biosimilars of Denosumab in Europe
Pharma Focus Europe
by
2d ago
Sandoz the global leader in generic and biosimilar medicines today announced that the European Commission has granted marketing authorization for Wyost ..read more
Visit website
Medigene and BioNTech Extend Their Global Research and Collaboration Agreement Beyond the Initially Announced Term
Pharma Focus Europe
by
2d ago
Medigene AG and BioNTech SE have announced the extension of their collaboration beyond the initial threeyear term outlined in February This extension reflects their commitment to advancing T cell ..read more
Visit website
Theriva™ Biologics Announces US FDA Fast Track Designation for VCN-01 for the Treatment of Metastatic Pancreatic Cancer
Pharma Focus Europe
by
2d ago
Theriva Biologics a diversified clinicalstage company developing therapies designed to treat cancer and related diseases in areas of high deprivation today announced that the US Food and Drug Administration ..read more
Visit website
Swixx Biopharma Expands into Latin America Through Acquisition and Merger with Biopas
Pharma Focus Europe
by
2d ago
Swixx BioPharma AG a global platform committed to improving access to innovative medicines worldwide has announced its strategic expansion into Latin America The company has finalized ..read more
Visit website
Oxford Nanopore Technologies and Twist Bioscience Partner to Introduce Beta Program for Advancing Personalized Medicine via Pharmacogenomics
Pharma Focus Europe
by
2d ago
Today Oxford Nanopore Technologies announced the launch of a new Pharmacogenomics Beta Program aimed at advancing personalized medicine This program combines Twist Biosciences ..read more
Visit website
DelsiTech Reveals Significant Licensing Agreement for Innovative Drug Delivery Solution
Pharma Focus Europe
by
2d ago
DelSiTech Ltd a company specializing in clinicalstage drug delivery and development has just unveiled a significant milestone Theyve inked a Licensing Agreement with a prominent global pharmaceutical entity ..read more
Visit website
Sarah Cannon Research Institute Expands into East Tennessee through Partnership with Tennessee Cancer Specialists
Pharma Focus Europe
by
2d ago
The Sarah Cannon Research Institute a leader in oncology research and communitybased clinical trials has announced a collaboration with Tennessee Cancer Specialists an independent oncology ..read more
Visit website
Abdera Therapeutics Receives FDA Clearance for ABD-147 IND Application
Pharma Focus Europe
by
2d ago
Abdera Therapeutics Inc a biopharmaceutical company specializing in precision radiopharmaceuticals for cancer treatment has received clearance from the US Food and Drug Administration for its Investigational New Drug application regarding ABD This marks a significant step forward ..read more
Visit website

Follow Pharma Focus Europe on FeedSpot

Continue with Google
Continue with Apple
OR